News & Videos - TG THERAPEUTICS INC.

LOS ANGELES, CA / ACCESSWIRE / September 27, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TG Therapeutics, Inc. ("TG Therapeutics" or "the Company") (NASDAQ:TGTX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. If you are a shareholder who suffered a loss,...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TG Therapeutics, Inc. - TGTX PR Newswire NEW YORK, Sept. 13, 2023 NEW YORK , Sept. 13, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. ("TG Therapeutics" or the "Company") (NASDAQ: TGTX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether TG Therapeutics and...

Thinking about buying stock in Nio Inc, Tupperware Brands, ZIM Integrated Shipping, Upstart Holdings, or TG Therapeutics? PR Newswire NEW YORK, July 31, 2023 NEW YORK , July 31, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NIO, TUP, ZIM, UPST, and TGTX. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. NIO:...

Thinking about buying stock in Virgin Galactic Holdings, TG Therapeutics, Lucid Group, Ainos, or PainReform? PR Newswire NEW YORK, July 14, 2023 NEW YORK , July 14, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SPCE, TGTX, LCID, AIMD, and PRFX. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. SPCE:...

Thinking about buying stock in Palisade Bio, Kala Pharmaceuticals, F-Star Therapeutics, Nuwellis, or TG Therapeutics? PR Newswire NEW YORK, Dec. 30, 2022 NEW YORK , Dec. 30, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PALI, KALA, FSTX, NUWE, and TGTX. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. PALI:...

Thinking about buying stock in Quotient, TAL Education, Core Scientific, TG Therapeutics, or Rivian Automotive? PR Newswire NEW YORK, Dec. 29, 2022 NEW YORK , Dec. 29, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for QTNT, TAL, CORZ, TGTX, and RIVN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. QTNT:...

FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm PR Newswire LOS ANGELES, Sept. 16, 2022 LOS ANGELES , Sept. 16, 2022 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against TG Therapeutics, Inc. ("TG Therapeutics" or "the Company") (NASDAQ: TGTX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule...

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against TG Therapeutics, Inc. (“TG Therapeutics” or the “Company”) (NASDAQ: TGTX) and certain of its officers, on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired TG Therapeutics securities between January 15, 2020 and May 31, 2022, both dates inclusive (the “Class Period”). Such investors are...

TGTX SHAREHOLDER ALERT: Jakubowitz Law Reminds TG Therapeutics Shareholders of a Lead Plaintiff Deadline of September 16, 2022 PR Newswire NEW YORK, Sept. 16, 2022 NEW YORK , Sept. 16, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of TG Therapeutics, Inc. (NASDAQ: TGTX). To receive updates on the lawsuit, fill out the form:...

TGTX DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Friday Deadline in Securities Class Action - TGTX PR Newswire NEW YORK, Sept. 15, 2022 NEW YORK , Sept. 15, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TG Therapeutics, Inc. (NASDAQ: TGTX) between January 15, 2020 and May 31, 2022 , both dates inclusive (the "Class Period"), of the important...

LOS ANGELES, CA / ACCESSWIRE / September 15, 2022 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against TG Therapeutics, Inc. ("TG Therapeutics" or "the Company") (NASDAQ:TGTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 15, 2020 and May 31, 2022,...

TGTX LAWSUIT ALERT: Levi & Korsinsky Notifies TG Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire NEW YORK, Sept. 15, 2022 NEW YORK , Sept. 15, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in TG Therapeutics, Inc. ("TG Therapeutics" or the "Company") (NASDAQ: TGTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of TG Therapeutics investors who were adversely affected by alleged...

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against TG Therapeutics, Inc. (“TG Therapeutics” or the “Company”) (NASDAQ: TGTX) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired TG Therapeutics securities between January 15, 2020 and May 31, 2022, both dates inclusive (the “Class Period”)....

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of TG Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 16, 2022 - (NASDAQ: TGTX) PR Newswire NEW YORK, Sept. 14, 2022 NEW YORK , Sept. 14, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of TG Therapeutics, Inc.. Shareholders who purchased shares of TGTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff...

TGTX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 16, 2022 in the Class Action Filed on Behalf of TG Therapeutics, Inc. Shareholders PR Newswire NEW YORK, Sept. 13, 2022 NEW YORK , Sept. 13, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of TG Therapeutics, Inc. (NASDAQ: TGTX) alleging that the Company violated federal securities laws. Class Period: January 15, 2020 to May 31, 2022 Lead...

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind TG Therapeutics Investors of a Lead Plaintiff Deadline of September 16, 2022 PR Newswire NEW YORK, Sept. 12, 2022 NEW YORK , Sept. 12, 2022 /PRNewswire/ -- Attention TG Therapeutics, Inc. ("TG Therapeutics") (NASDAQ: TGTX) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between January 15, 2020 and May 31, 2022 . If you suffered a loss on your...

TGTX SHAREHOLDER ALERT: Jakubowitz Law Reminds TG Therapeutics Shareholders of a Lead Plaintiff Deadline of September 16, 2022 PR Newswire NEW YORK, Sept. 9, 2022 NEW YORK , Sept. 9, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of TG Therapeutics, Inc. (NASDAQ: TGTX). To receive updates on the lawsuit, fill out the form:...

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important September 16 Deadline in Securities Class Action - TGTX PR Newswire NEW YORK, Sept. 8, 2022 NEW YORK , Sept. 8, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TG Therapeutics, Inc. (NASDAQ: TGTX) between January 15, 2020 and May 31, 2022 , both dates inclusive (the "Class Period"), of the important September 16,...

TGTX LAWSUIT ALERT: Levi & Korsinsky Notifies TG Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire NEW YORK, Sept. 8, 2022 NEW YORK , Sept. 8, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in TG Therapeutics, Inc. ("TG Therapeutics" or the "Company") (NASDAQ: TGTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of TG Therapeutics investors who were adversely affected by alleged...

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of TG Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 16, 2022 - (NASDAQ: TGTX) PR Newswire NEW YORK, Sept. 7, 2022 NEW YORK , Sept. 7, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of TG Therapeutics, Inc.. Shareholders who purchased shares of TGTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment....